Lonza Stock - weekly outlook with earnings ahead
22.06.2026 - 04:45:22 | ad-hoc-news.de
Edited by ad hoc news Earnings & Calendar Desk. Verified prior to publication on 06/22/2026, 02:40 UTC. Details in the imprint.
Lonza (CH0013841017) starts the new week without a fresh market-moving announcement from management or regulators. Investors are instead orienting themselves toward the next scheduled earnings date and the company’s medium-term margin ambitions.
All news and key data on Lonza stock
Further corporate releases, historical news and price data help frame Lonza’s position in the life-sciences tools sector over the coming quarters.
What the calendar shows next
Lonza’s investor-relations calendar lists the next half-year and full-year results as the key dated events for shareholders, alongside regular capital markets presentations and industry conferences. The company typically publishes detailed dates and formats on its IR site.
According to the investor-relations section, Lonza continues to organize updates around half-year and full-year milestones, with additional appearances at healthcare and chemicals conferences that often include slide decks on strategy and capital allocation.
How consensus views the upcoming period
While no new analyst rating was published today, the stock remains covered by a broad group of European and US banks that update their models around quarterly reporting and significant contract announcements. Consensus data are usually compiled by financial data providers.
These consensus figures aggregate expectations for revenue growth, core EBITDA margin and capital expenditure over the next one to three years, offering a structured view of how the market currently prices Lonza’s role as a contract manufacturer to the pharma and biotech industry.
What the company sells
Lonza generates most of its revenue as a contract development and manufacturing organization for the biopharmaceutical industry, producing active ingredients and finished dosage forms for biologics and small molecules under long-term supply agreements with global drugmakers.
Where the stock trades today
Lonza shares trade on SIX Swiss Exchange in Zurich; the latest available quote shows the stock changing hands in Swiss francs, with intraday levels and market capitalization data provided by the Swiss exchange’s official price feed.
Key facts on Lonza stock
- Company: Lonza Group AG
- ISIN: CH0013841017
- Venue: SIX Swiss Exchange
- Sector / Industry: Health Care - Life Sciences Tools & Services
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
